Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Smither John W
Relationship:   Director
City:   Calabasas
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   89,084    

Indirect Shares

   176,353      
Direct Value   $115,605    

Indirect Value

   $1,108,513      
Total Shares   265,437      
Total Value   $1,224,119      


Sienna Biopharmaceuticals, Inc. $0 Arcutis Biotherapeutics, Inc. $89,102 Effector Therapeutics Ord Shs $0 Genelux Corp $26,504 Sienna Biopharmaceuticals, Inc. $0 Arcutis Biotherapeutics, Inc. $89,102 Effector Therapeutics Ord Shs $0 Genelux Corp $26,504
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -81.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Kythera Biopharmaceuticals Inc KYTH Chief Financial Officer 2015-10-01 0 2015-10-01 0    Premium*  
            Sienna Biopharmaceuticals, Inc. SNNA 2019-01-01 46,657 2019-01-01 34,961    Premium*  
            Arcutis Biotherapeutics, Inc. ARQT Chief Financial Officer 2024-02-13 11,365 2024-02-13 141,392    Premium*  
            Effector Therapeutics Ord Shs EFTR Director 2021-08-25 24,142 2021-08-25 0    Premium*  
            Genelux Corp GNLX Director 2023-09-13 6,920 2023-09-11 0    Premium*  
* Premium Members only  

Records found :    99         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-05-01 4 OE $1.35 $5,400 D/D 4,000 4,000 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-05-01 4 AS $24.11 $96,429 D/D (4,000) 0 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-06-17 4 OE $1.35 $8,100 D/D 6,000 6,000 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-06-17 4 AS $26.00 $156,000 D/D (6,000) 0 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-08-01 4 OE $1.35 $13,500 D/D 10,000 10,000 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-08-01 4 AS $26.80 $268,005 D/D (10,000) 0 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-09-09 4 AS $30.00 $300,000 D/D (10,000) 0 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-09-09 4 OE $1.35 $13,500 D/D 10,000 10,000 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-09-10 4 OE $1.35 $40,500 D/D 30,000 30,000 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-09-10 4 AS $30.03 $900,996 D/D (30,000) 0 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-11-06 4 OE $1.35 $12,150 D/D 9,000 9,000 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2013-12-16 4 OE $1.35 $1,620 D/D 1,200 10,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-01-21 4 AS $42.54 $47,856 D/D (1,125) 10,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-01-21 4 OE $5.90 $6,638 D/D 1,125 11,325 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-02-14 4 OE $5.90 $6,638 D/D 1,125 11,325 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-02-14 4 AS $50.00 $56,250 D/D (1,125) 10,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-02-20 4 OE $5.90 $13,275 D/D 2,250 12,450 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-02-20 4 AS $49.75 $111,926 D/D (2,250) 10,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-03-20 4 AS $43.78 $49,253 D/D (1,125) 10,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-03-20 4 OE $5.90 $6,638 D/D 1,125 11,325 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-03-26 4 OE $1.35 $4,050 D/D 3,000 13,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-04-21 4 OE $5.90 $2,213 D/D 375 13,575 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-04-21 4 AS $36.12 $13,545 D/D (375) 13,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-05-20 4 AS $32.20 $12,075 D/D (375) 13,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-05-20 4 OE $5.90 $2,213 D/D 375 13,575 0 -
  99  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us